Seneca biopharma, inc. (CUR)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
CURRENT ASSETS
Cash and cash equivalents

10,030

5,114

7,299

2,281

4,005

5,787

5,736

7,092

9,724

6,674

9,063

6,442

11,680

15,194

5,676

11,128

7,620

4,716

13,130

8,649

13,593

12,518

11,945

15,232

18,342

16,846

16,401

11,166

12,659

7,443

9,873

2,539

5,144

2,352

4,195

6,141

9,261

Short-term investments

-

-

-

-

-

-

0

0

0

5,000

5,000

5,000

5,000

5,000

0

0

0

7,517

5,017

15,032

15,032

15,007

15,007

15,000

15,000

0

-

-

-

-

-

-

-

-

-

-

-

Trade and other receivables

19

21

61

169

237

294

161

478

137

312

37

5

14

10

12

5

39

37

19

18

8

225

32

24

11

10

7

56

104

3

0

56

234

234

-

-

-

Current portion of related party receivable, net of discount

-

-

-

-

-

63

62

0

0

58

57

0

0

53

51

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing fees, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

107

121

130

135

339

389

435

507

575

591

557

0

-

-

-

-

-

-

-

Prepaid expenses

414

510

605

256

295

363

545

343

346

402

548

239

477

646

946

705

1,077

1,159

1,289

904

388

274

409

196

319

255

343

156

220

205

289

234

404

430

653

300

246

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

322

Total current assets

10,463

5,646

7,966

2,708

4,538

6,508

6,506

7,914

10,208

12,448

14,707

11,687

17,172

20,904

6,687

11,839

8,737

13,431

19,563

24,725

29,152

28,161

27,734

30,842

34,109

17,619

17,328

11,971

13,542

7,652

10,164

2,830

5,783

3,016

4,849

6,448

9,830

Property and equipment, net

31

41

51

63

75

90

107

128

149

172

196

219

242

269

315

363

336

343

335

342

282

301

301

310

310

230

253

189

207

230

246

269

266

292

312

335

200

Patents, net

649

668

688

713

738

763

788

814

839

883

915

945

904

990

984

1,034

1,066

1,103

1,147

1,205

1,242

1,233

1,245

1,247

1,190

1,137

1,047

984

876

807

772

798

721

701

658

566

500

Related party receivable, net of discount and current portion

-

-

-

-

-

298

290

343

334

365

356

402

392

424

413

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

ROU and other assets

215

227

237

-

-

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing fees, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

40

62

89

104

169

248

360

470

592

725

0

-

-

-

-

-

-

-

Other assets

-

-

-

36

53

-

28

33

18

13

13

13

15

15

49

57

57

71

72

57

59

58

57

58

64

64

64

59

59

59

59

59

75

75

68

68

60

Total assets

11,360

6,583

8,943

3,521

5,405

7,684

7,721

9,233

11,549

13,884

16,188

13,268

18,728

22,604

8,450

13,294

10,198

14,949

21,141

26,372

30,798

29,844

29,443

32,628

35,923

19,413

19,165

13,798

15,411

8,750

11,241

3,957

6,846

4,086

5,888

7,420

10,591

CURRENT LIABILITIES
Accounts payable and accrued expenses

961

824

1,181

1,051

1,083

832

835

713

1,169

875

1,476

2,235

2,167

2,343

2,484

2,501

2,627

1,455

2,036

2,099

2,129

2,504

-

-

-

1,196

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52

-

-

Accrued bonuses

98

135

-

-

-

-

0

0

0

418

0

0

0

852

0

0

287

161

767

490

225

646

-

-

-

465

462

313

410

465

479

319

657

582

539

381

453

Short-term note and other current liabilities

126

264

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short term notes and other current liabilities

126

264

400

-

-

218

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,444

2,025

1,771

-

1,212

812

1,243

1,199

1,501

1,149

1,654

1,843

1,394

773

1,032

Current portion of long-term debt, net of fees and discount

-

-

-

-

-

-

-

-

-

-

0

0

2,530

3,705

4,829

5,905

4,466

4,545

4,457

3,170

1,929

730

3,058

2,952

2,849

2,763

1,986

1,235

510

0

-

-

-

-

-

-

-

Derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,417

1,311

633

445

0

-

-

-

-

-

-

1,250

Other current liabilities

-

-

-

19

126

-

348

52

109

220

358

67

349

430

538

204

241

263

207

148

52

126

202

13

53

93

174

10

42

90

138

-

-

0

-

-

-

Total current liabilities

1,186

1,224

1,581

1,071

1,210

1,051

1,184

766

1,279

1,514

1,834

2,303

5,047

7,333

7,852

8,611

7,621

6,425

7,469

5,909

4,336

4,008

5,704

4,991

4,674

5,936

5,147

3,006

2,653

1,756

2,119

1,468

2,312

2,426

1,986

1,154

2,737

Long-term debt, net of fees, discount and current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,546

3,382

4,625

5,812

6,954

8,056

2,611

3,415

4,192

4,934

5,661

6,363

7,042

0

-

-

-

-

-

-

-

Warrant liabilities, at fair value

59

84

166

487

923

583

2,047

2,283

3,662

3,852

2,785

3,267

3,884

3,921

4,363

3,824

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability, net of current portion

136

148

152

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long term liabilities

-

-

-

-

-

-

9

8

1

1

3

4

16

18

20

21

200

174

143

110

146

59

222

192

160

124

89

55

22

21

-

-

-

-

-

-

-

Deferred rent, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

Deferred rent, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

-

-

-

-

-

-

Total liabilities

1,382

1,457

1,900

1,559

2,133

1,634

3,241

3,058

4,942

5,369

4,623

5,575

8,948

11,273

12,235

12,458

10,368

9,982

12,238

11,832

11,437

12,124

8,539

8,599

9,027

10,995

10,898

9,425

9,717

1,777

2,143

1,468

2,312

2,426

1,986

1,154

2,737

Commitments and contingencies (Note 5)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

-

-

0

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

-

-

0

STOCKHOLDERS' EQUITY
Preferred stock, 7,000,000 shares authorized, $0.01 par value; 200,000 shares issued and outstanding at March 31, 2020 and December 31, 2019

2

2

2

5

10

10

10

10

10

10

10

10

10

10

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.01 par value; 300,000,000 shares authorized, 9,428,011 and 3,866,457 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

94

38

28

10

182

9

152

151

151

151

151

120

117

110

1,148

1,147

920

70

917

903

903

877

871

868

866

778

766

706

687

681

679

540

540

486

486

484

468

Additional paid-in capital

239,439

227,067

226,957

220,125

219,819

219,654

217,619

217,485

217,289

217,050

216,784

212,809

210,249

204,239

182,699

182,101

177,473

176,852

175,174

175,185

174,560

167,890

165,577

164,250

160,368

136,058

132,617

122,142

117,190

114,884

114,297

105,249

104,919

99,645

99,331

98,485

93,339

Accumulated other comprehensive loss

-7

-6

-7

-3

-2

-0

0

1

2

2

2

3

3

3

4

4

1

3

3

5

6

6

6

6

5

7

6

-

-

0

-

-

-

-

-

-

-

Accumulated deficit

-229,550

-221,975

-219,937

-218,174

-216,737

-213,623

-213,303

-211,473

-210,846

-208,699

-205,383

-205,249

-200,600

-193,033

-187,637

-182,416

-178,564

-171,958

-167,193

-161,555

-156,107

-151,054

-145,551

-141,096

-134,345

-128,426

-125,122

-118,435

-112,184

-108,594

-105,879

-103,301

-100,925

-98,472

-95,916

-92,704

-85,954

Total stockholders' equity

9,977

5,125

7,042

1,962

3,271

6,049

4,479

6,175

6,607

8,515

11,564

7,692

9,779

11,330

-3,784

836

-169

4,967

8,902

14,539

19,361

17,719

20,903

24,028

26,896

8,418

8,266

4,412

5,693

6,972

9,098

2,488

4,534

1,659

3,902

6,265

7,854

Total liabilities and stockholders' equity

11,360

6,583

8,943

3,521

5,405

7,684

7,721

9,233

11,549

13,884

16,188

13,268

18,728

22,604

8,450

13,294

10,198

14,949

21,141

26,372

30,798

29,844

29,443

32,628

35,923

19,413

19,165

13,798

15,411

8,750

11,241

3,957

6,846

4,086

5,888

7,420

10,591